on 29 Mar 2022
Last Applicant/ Owned by
F-59120 LOOS
FR
Serial Number
79312182 filed on 20th Jan 2021
Registration Number
6681657 registered on 29th Mar 2022
Correspondent Address
Brooks R. Bruneau
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmRead More
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use
Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services
No 79312182
No Service Mark
No 04774.T980US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 29th Jun 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 08th May 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| 29th Mar 2022 | REGISTERED-PRINCIPAL REGISTER |
| 11th Jan 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 11th Jan 2022 | PUBLISHED FOR OPPOSITION |
| 10th Jan 2022 | NOTIFICATION PROCESSED BY IB |
| 22nd Dec 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 22nd Dec 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 22nd Dec 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 09th Dec 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
